Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2026 Earnings Call Transcript
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2026 Earnings Call Transcript May 13, 2026Takeda Pharmaceutical Company Limited beats earnings expectations.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Adage Capital Management Phill Gross And Robert Atchinson | 6,424,984 | $118,990,704 | 0.18% | |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,116,311 | $57,714,080 | -46% | 0.03% |
| 3. | Renaissance Technologies Jim Simons | 2,989,100 | $55,358,132 | +15% | 0.09% |
| 4. | D E Shaw D. E. Shaw | 2,602,543 | $48,199,096 | -40% | 0.03% |
| 5. | 1,509,500 | $27,955,940 | -5% | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,104,219 | $353,810,136 | 0.05% | |
| 2. | 7,117,486 | $131,815,844 | 0.01% | |
| 3. | 6,469,600 | $119,817,018 | 0.01% | |
| 4. | 5,618,728 | $104,058,841 | 0.01% | |
| 5. | 4,430,642 | $82,055,682 | 0.58% |